Supplementary Figure S4 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Aparna R. Parikh; Bryant H. Chee; Jill Tsai; Thereasa A. Rich; Kristin S. Price; Sonia Patel; Li Zhang; Faaiz Ibrahim; Mikaela Esquivel; Emily E. Van Seventer; Joy X. Jarnagin; Victoria M. Raymond; Carlos U. Corvera; Kenzo Hirose; Eric K. Nakakura; Ryan B. Corcoran; Katherine Van Loon; Chloé E. Atreya

doi:10.1158/1078-0432.26302437.v1

July 15, 2024

Supplementary Figure S4 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

View at Publisher

Ask AI

Bookmark

Share

Key Points

Survival outcomes and recurrence rates differ when stratified by CEA status following curative intent treatment for metastatic colorectal cancer, identifying patients at risk.
Assessment of minimal residual disease evaluates a plasma-only circulating tumor DNA assay to track recurrence after curative intent treatment for metastatic colorectal cancer.
Highlights the utility of measuring circulating tumor DNA alongside standard CEA status to detect minimal residual disease and guide clinical follow-up in post-treatment care.

Implication

Assessment reveals survival outcomes and recurrence rates stratified by CEA status in metastatic colorectal cancer, highlighting potential biomarkers for post-treatment monitoring.

Abstract

Supplementary Figure S4. Survival outcomes and recurrence rates stratified by CEA status.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Parikh et al. (2024) studied this question.

synapsesocial.com/papers/68e60477b6db643587598510 https://doi.org/10.1158/1078-0432.26302437.v1

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S4 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Key Points

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure S4 from Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers